Combination of GLP‐1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study

AIMS: Intensification of type 2 diabetes (T2DM) treatment with GLP‐1 receptor agonists (GLP‐1RAs) promotes weight loss. We aimed to determine the synergistic effect of behavioural programmes on body weight on top of GLP‐1RA treatment. MATERIALS AND METHODS: We retrospectively analysed the time cours...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Endocrinol Diabetes Metab
Prif Awduron: Petroni, Maria Letizia, Montesi, Luca, Colosimo, Santo, Caletti, Maria Turchese, Mazzotti, Arianna, Marchesini, Giulio
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2019
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6775466/
https://ncbi.nlm.nih.gov/pubmed/31592154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.82
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg